To: Starlight who wrote (4018 ) 11/15/1997 6:42:00 PM From: Bilberry Read Replies (2) | Respond to of 9695
It looks like JMAR is raising more money to fund its emerging technologies (looks like restricted shares)....This would raise about $10 million shares, and add a little more than 3 million shares to the float and 772,059 shares when the warrants are excercised. Maybe this accounts for the price decline. Any comments? In addition, the Company may require additional outside financing for some of its emerging products including 1) the continued development of advanced lithography light sources and workstations for the manufacture of new generations of higher performance semiconductor chips; 2) the ultra-precision manufacturing programs featuring the Britelight and Microlight systems that utilize the Company's patented, new short-pulse laser technology for a range of near term advanced manufacturing applications; and 3) the Company's emerging Light Knife series of hand-held lasers designed primarily for medical applications such as needle-less blood sampling but which the Company believes can also be utilized in the dental and ophthalmic markets, as well. In connection with the above financing needs along with financing that may be required for future acquisitions and general working capital, the Company has retained Baytree Associates, Incorporated to arrange financing (the "Offering") for the Company consisting of the private offering, on a "best efforts" basis, of up to 772,059 Units at a price of $13.60 per Unit. Each Unit consists of four shares of common stock and one Warrant to purchase one additional share of common stock at a price of $4.40 per share. As of November 11, 1997, the Company has received subscriptions to purchase 251,838 Units for $3,425,000. The sale of these Units has not been completed and no proceeds from the Offering have been received by the Company. There is no assurance that all or any portion of the Offering will be completed.